Latest | F'cast | |
---|---|---|
Div Yield | 3.0% | 0.0% |
Div Cover | 2.3 | 2.1 |
Op Mrgn | 11.5% | 16.4% |
ROCE | 42.4% |
Latest | F'cast | |
---|---|---|
P/E | 14.9 | 14.6 |
PEG | 1.3 | n/a |
Pr/Revenue | 2.1 | 1.9 |
Pr/Book | 1.4 |
Latest | F'cast | |
---|---|---|
Revenue | 7.9% | 4.0% |
PBT | 51.3% | 54.1% |
EPS | 11.8% | -2.7% |
DPS | 11.9% | 5.5% |
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
30-Sep-18 | 306.04 | 39.66 | 17.40p | 28.4 | 1.3 | +22% | 7.50p | 1.5% |
30-Sep-19 | 355.70 | 57.72 | 21.30p | 27.6 | 1.3 | +22% | 8.75p | 1.5% |
30-Sep-20 | 355.80 | 58.70 | 19.90p | 28.4 | n/a | -7% | 9.00p | 1.6% |
30-Sep-21 | 694.50 | 55.00 | 23.80p | 26.3 | 1.3 | +20% | 10.50p | 1.7% |
30-Sep-22 | 749.20 | 83.20 | 26.60p | 12.0 | 1.0 | +12% | 11.75p | 3.7% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
30-Sep-23 | 779.24 | 128.18 | 25.89p | 15.3 | n/a | -3% | 12.39p | 0.0% |
30-Sep-24 | 814.26 | 140.36 | 28.16p | 14.1 | 1.6 | +9% | 13.47p | 0.0% |
30-Sep-25 | 855.78 | 159.40 | 30.51p | 13.0 | 1.6 | +8% | 13.93p | 0.0% |
Copyright © 2023 FactSet Research Systems Inc. All rights reserved.
Posting of Annual Report and Notice of AGM | 27-Jan-2023 | 07:00 | RNS |
Director/PDMR Shareholding | 25-Jan-2023 | 07:00 | RNS |
Option exercise and increase in share capital | 18-Jan-2023 | 07:00 | RNS |
RWS turns in strong full-year results | 15-Dec-2022 | ShareCast |
Berenberg reiterates 'buy' rating on RWS Holdings | 15-Dec-2022 | ShareCast |
Director dealings: RWS director linked to £28k p... | 07-Nov-2022 | ShareCast |
No deals were found in the last 28 days.
Currency | UK Pounds |
Share Price | 396.40p |
Change Today | 20.60p |
% Change | 5.48 % |
52 Week High | 512.00 |
52 Week Low | 264.40 |
Volume | 957,132 |
Shares Issued | 389.44m |
Market Cap | £1,543.74m |
RiskGrade | 161 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Strong Buy | 1 |
Buy | 2 |
Neutral | 1 |
Sell | 0 |
Strong Sell | 0 |
Total | 4 |
Latest | Previous | |
---|---|---|
Final | Interim | |
Ex-Div | 26-Jan-23 | 23-Jun-22 |
Paid | 24-Feb-23 | 22-Jul-22 |
Amount | 9.50p | 2.25p |
Time | Volume / Share Price |
16:37 | 578 @ 396.40p |
16:37 | 1,604 @ 396.40p |
16:37 | 1,818 @ 396.40p |
16:35 | 158,250 @ 396.40p |
16:35 | 861 @ 396.40p |
Chair | Andrew Brode |
CFO | Candida (Candy) Davies |
You are here: research